Field	Value
Document ID	RPL-FAQ-TDS-001
Document Type	FAQ
Category	Documentation — Technical Data Sheet
Publisher	RPL Peptide (Qingdao RPL Biotechnology Co., Ltd.)
Version	1.0
Revision Date	July 2026
Status	Current
URL	https://rplpeptides.com

Technical Data Sheet (TDS) FAQ¶

(1) TDS Overview¶

Q1: What is a Technical Data Sheet (TDS) for research peptides?¶

A: A Technical Data Sheet (TDS) is a document that provides comprehensive product reference information for a specific peptide, including its chemical properties, quality specifications, analytical methods, solubility data, storage recommendations, and handling guidelines.

The TDS serves as the first point of reference for anyone evaluating or using a peptide product. It answers questions such as: - What is the molecular weight and chemical formula of this peptide? - What are the specified purity and content requirements? - What analytical method is used for purity testing? - In what solvent should this peptide be reconstituted? - How should it be stored?

Unlike the COA (which is batch-specific), the TDS is a general product document that applies to all batches of a given product until revised.

Q2: What information does a typical TDS contain?¶

A: A well-structured peptide TDS includes the following information sections:

Section	Information Provided
Product Identification	Product name, catalog number(s), synonyms
Chemical Properties	Amino acid sequence, molecular formula, molecular weight, CAS number, counter-ion form
Quality Specifications	Purity specification (e.g., ≥98%), assay range, appearance specification, pH range, endotoxin limit, water content limit
Analytical Methods	HPLC column, gradient, detection wavelength, MS ionization method
Solubility	Recommended solvents (water, PBS, DMSO, ethanol), typical achievable concentration ranges
Storage & Stability	Recommended storage temperature, shelf life, handling precautions
Safety & Handling	GHS classification summary, required PPE
Document Control	Document ID, version number, revision date, approval

This information is consistent across all batches and forms the specification baseline against which each batch's COA results are compared.

Q3: How is a TDS different from a COA and an SDS?¶

A: These three documents serve complementary but distinct roles:

Aspect	TDS	COA	SDS
Purpose	Product specifications and properties	Batch-specific test results	Safety, hazards, and handling
Batch-specific?	No (general product)	Yes (specific to one batch)	No (general product)
Changes between batches	No — specs are fixed	Yes — test results vary by batch	No — hazards are product-inherent
When to refer to it	First evaluation, reconstitution, storage planning	Upon receipt and before use	Before handling, for safety compliance
Key data	MW, sequence, solubility, specifications	Purity, identity, content, water by actual measurement	GHS classification, PPE, first aid, disposal
Format standard	Company-defined	Company-defined	GHS 16-section mandatory

Practical workflow: 1. Use the TDS to understand the product and determine if it suits your application 2. Receive the COA with your shipment to verify the specific batch quality 3. Consult the SDS for safe handling, storage, and emergency procedures

Q4: Where can I find solubility and reconstitution information for my peptide?¶

A: The TDS is the primary source for solubility and reconstitution recommendations. Typical information includes:

Common solvents for peptide reconstitution: | Solvent | Typical Use | Notes | |---------|-------------|-------| | Water (HPLC-grade) | First choice for most hydrophilic peptides | Use sterile, deionized water | | Phosphate-buffered saline (PBS) | Biological assays | Maintains physiological pH | | Acetic acid (0.1–1%) | Peptides with poor water solubility | Helps dissolve basic peptides | | DMSO | Highly hydrophobic peptides | Use sparingly; may affect cell-based assays | | Acetonitrile/water mixtures | For LC-MS analysis | Not for biological use |

If solubility information is not on the TDS: - Start with water (most peptides are at least partially water-soluble) - Try 0.1% acetic acid or TFA in water for difficult-to-dissolve peptides - Add small amounts of organic solvent (DMSO, ACN) incrementally - Sonicate briefly (without heating) to aid dissolution

If you have specific solubility concerns, contact RPL Peptide's technical support for peptide-specific guidance.

(2) Document Control¶

Q5: What is a Document ID and how is it structured?¶

A: A Document ID is a unique alphanumeric code assigned to each document in a quality management system. It allows unambiguous identification and cross-referencing between documents. At RPL Peptide, Document IDs follow a structured format:

RPL - XX - XXX - 001
│     │     │      │
│     │     │      └── Sequence number (001, 002, etc.)
│     │     └───────── Product or topic code
│     └─────────────── Document type code
└───────────────────── Company prefix

Document type examples: | Code | Document Type | |:----:|---------------| | WP | White Paper (educational) | | FAQ | Frequently Asked Questions | | TDS | Technical Data Sheet | | COA | Certificate of Analysis | | SDS | Safety Data Sheet | | TM | Technical Manual | | SOP | Standard Operating Procedure |

Example: RPL-TDS-BPC157-001 = RPL Peptide, Technical Data Sheet, BPC-157, sequence 001.

Key properties of a Document ID: - Unique: No two documents share the same ID - Persistent: The ID remains the same across all revisions - Structured: Encodes document type and topic at a glance - Cross-referenceable: White papers can reference TDS documents by ID, and COAs reference batch numbers

Q6: What is version control and why does it matter for TDS documents?¶

A: Version control is a systematic process for managing changes to documents, ensuring the current version is clearly identified and previous versions are archived and retrievable. In a quality management system, version control is essential because:

Ensures everyone uses the correct version of specifications and methods
Maintains an auditable history of all changes
Prevents confusion when specifications are updated
Supports regulatory compliance and quality audits

Version control elements for a TDS: | Element | Description | Example | |---------|-------------|---------| | Version number | Sequential identifier for each release | 1.0, 1.1, 2.0 | | Revision date | Date the version was issued | July 2026 | | Document status | Current, superseded, or obsolete | Current | | Author/owner | Person or department responsible | Quality Department | | Change history log | Table of what changed, when, and why | See revision history |

RPL Peptide uses major.minor version numbering: major revisions (1.0 → 2.0) for significant content changes (specification changes, new methods), and minor revisions (1.0 → 1.1) for corrections, formatting, or clarifications.

Q7: What is the document revision history and how do I read it?¶

A: The revision history (or change history) is a table at the end of a TDS that records every change made to the document throughout its lifecycle. It allows users to see at a glance what has changed and when.

Standard revision history table format: | Version | Date | Author | Changes | |:-------:|:----:|--------|---------| | 1.0 | July 2026 | RPL Peptide Quality | Initial release | | 1.1 | October 2026 | RPL Peptide Quality | Updated solubility data; added pH specification | | 2.0 | March 2027 | RPL Peptide Quality | Revised purity specification (≥99%); updated HPLC method |

How to read it: - Version 1.0: Original document — no prior history - Version 1.1: Minor update — solubility and pH details added, but no specification changes - Version 2.0: Major update — purity specification was raised and the analytical method was updated

Why this matters: If you have a TDS from 2026 but the current revision is 2.0 from March 2027, you may be working with outdated specifications. Always check the revision history to determine if the document you have is current.

Q8: How do I know if I have the latest version of a TDS?¶

A: To confirm you have the latest version of a TDS:

Check the revision date on the first page or header of the document
Compare the version number with the latest published version on the supplier's website or document portal
Review the revision history at the end of the document — the most recent entry should be at the top
Contact the supplier if you are unsure — reputable suppliers maintain a document register and can confirm the current version

RPL Peptide publishes the current revision date on all TDS documents. The revision date and version number are clearly displayed on each page header or the cover page.

If you have been using a saved copy from a previous purchase, always verify the version against the supplier's current documentation before referencing it for experimental planning.

(3) Managing Revisions¶

Q9: What is the difference between major and minor revisions?¶

A: The distinction between major and minor revision levels helps users quickly assess whether a change requires their attention:

Aspect	Minor Revision	Major Revision
Version change	X.Y → X.(Y+1), e.g., 1.0 → 1.1	(X+1).0, e.g., 1.0 → 2.0
Typical changes	Corrections, formatting, clarifications, additional data	Specification changes, new methods, regulatory updates
User impact	Low — existing data remains valid	High — may affect experimental design or results
Review needed?	Informational review recommended	Full review required before continued use
Examples	Fixing a typo, adding a note on solubility, updating contact info	Changing purity specification from ≥95% to ≥98%, updating HPLC gradient method

When a major revision occurs, users should: - Read the new version in full - Update their reference materials - Check if the changes affect current or planned experiments - Replace old copies with the new version

Q10: What triggers a revision to a TDS?¶

A: A TDS is revised whenever there is a change to the product or its documentation that affects the information presented. Common triggers include:

Product changes: - Change in purity specification (e.g., ≥98% → ≥99%) - Change in salt form (e.g., TFA to acetate) - New analytical method adopted for routine QC - Updated solubility data from new studies - Changes in packaging or storage recommendations

Regulatory or standards changes: - Updates to GHS classification requirements affecting safety sections - New regulatory requirements affecting documentation format - Changes to pharmacopoeial standards (USP, EP, Ph. Eur.)

Quality system improvements: - Correction of errors found in previous versions - Improved clarity or additional detail for user guidance - Updated company information, contact details, or references

Documentation lifecycle: - Periodic review confirms the TDS is still accurate (or identifies needed updates) - Supersession: When a new version is released, the old one is archived and clearly marked as superseded

Q11: What do I do if my TDS is outdated compared to the latest version?¶

A: If you discover that your TDS is not the current version:

Obtain the latest version from the supplier's website, document portal, or by direct request
Compare the changes — use the revision history to understand what changed and why
Assess the impact on your work:
Minor changes (typos, formatting): Update your records, no experimental impact
Specification changes: Check if your current product batch meets the new or old spec
Method changes: Review if the new method is comparable to the old one for data consistency
Replace old copies — archive the superseded version per your document retention policy and circulate the new version
Update references — if you cite the TDS in your lab records or publications, update the version and revision date

RPL Peptide maintains all current TDS documents and can provide the latest version upon request.

Q12: How does document traceability apply to TDS documents?¶

A: Document traceability is the ability to track a document from creation through each revision to obsolescence. For TDS documents, this means:

The traceability chain: 1. Creation: Author creates the initial TDS; Document ID assigned 2. Review: Technical review of content accuracy; quality review for compliance 3. Approval: Authorized signatory approves the document for release 4. Distribution: Document is published and made available to customers 5. Revision: When changes are needed, a new version is created with documented change rationale 6. Supersession: The old version is archived and clearly marked as superseded 7. Reference cross-linking: The TDS references related documents (COA by batch, SDS by document ID)

Why traceability matters for users: - If specifications change between versions, traceability records explain the reason - In an audit, you can demonstrate which version of the TDS was current when you used the product - Cross-referencing between TDS, COA, and SDS builds a complete quality picture - A supplier with mature document traceability demonstrates commitment to quality management

RPL Peptide's documentation system maintains full traceability for all TDS documents, supporting both internal quality audits and customer inquiries.

Revision History¶

Version	Date	Author	Changes
1.0	July 2026	RPL Peptide Quality	Initial release

rplpeptides.com